Androgens contribute to the stimulation of cancellous bone formation by ovarian hormones in female rats

American Journal of Physiology - Endocrinology and Metabolism

Volumn 270, Issue 3 33-3, 1996, Pages

  Gallagher, A C ^a   Chambers, T J ^a   Tobias, J H ^a  

^a ST GEORGE S HOSPITAL   (United Kingdom)

Author keywords

5 dihydrotestosterone; flutamide; histomorphometry

Indexed keywords

ANDROGEN; ANDROSTANOLONE; FLUTAMIDE; HORMONE; PAMIDRONIC ACID;

ANIMAL TISSUE; ARTICLE; BODY WEIGHT; BONE TURNOVER; CANCELLOUS BONE; CONTROLLED STUDY; FEMALE; MORPHOMETRICS; NONHUMAN; OSSIFICATION; OVARIECTOMY; PRIORITY JOURNAL; RAT; UTERUS WEIGHT;

EID: 0029931858     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.1996.270.3.e407     Document Type: Article

References (31)

1. Beneton, M. N. C., E. V. McCloskey, A. J. P. Yates, S. Rogers, and J. A. Kanis. Stanozolol stimulates remodelling of trabecular bone and the net formation of bone at the endocortical surface. In: Third International Symposium on Osteoporosis, edited by C. Christiansen. Copenhagen: Osteopress, 1990, p. 1399-1400.
2. Buchanan, J. R., P. Hospodar, C. Myers, P. Leuenberger, and L. M. Demers. Effect of excess endogenous androgens on bone density in young women. J. Clin. Endocrinol. Metab 67: 937-943, 1988.
3. Chow, J., J. H. Tobias, K. W. Colston, and T. J. Chambers. Estrogen maintains trabecular bone volume in rats not only by suppression of bone resorption but also by stimulation of bone formation. J. Clin. Invest. 89: 74-78, 1992.
4. Chow, J. W. M., J. M. Lean, and T. J. Chambers. 17β-Estradiol stimulates cancellous bone formation in female rats. Endocrinology 130: 3025-3032, 1992.
5. Christiansen, C., M. S. Christiansen, N.-E. Larsen, and I. Transbol. Pathophysiological mechanism of estrogen effect on bone metabolism: dose-response relationship in early postmenopausal women. J. Clin. Endocrinol. Metab. 55: 1124-1130, 1982.
6. Colvard, D. S., E. F. Eriksen, P. E. Keeting, E. M. Wilson, D. B. Lubahn, F. S. French, B. L. Riggs, and T. C. Speisberg. Identification of androgen receptors in normal human osteoblast-like cells. Proc. Natl. Acad. Sci. USA 86: 854-857, 1989.
7. Dupon, C., and M. Kim. Peripheral plasma levels of testosterone, and rostenedione and estradiol during the rat estrous cycle. J. Endocrinol. 59: 653-654, 1973.
8. Goulding, A., and A. Gold. Flutamide-rnediated androgen blockade evokes osteopenia in the female rat. J. Bone Miner. Res. 8: 763-769, 1993.
9. Kalu, D. N. The ovariectomised rat model of postmenopausal bone loss. Bone Miner. 15: 175-192, 1991.
10. Kasperk, C. H., J. E. Wergedal, J. R. Farley, T. A. Linkhart, R. T. Turner, and D. J. Baylink. Androgens directly stimulate proliferation of bone cells in vitro. Endocrinology 124: 1576-1578, 1989.
11. Lean, J. M., J. W. M. Chow, and T. J. Chambers. The rate of cancellous bone formation falls immediately after ovariectomy in the rat. J. Endocrinol. 142: 119-125, 1994.
12. Leuenberger, P. K., J. R. Buchanan, C. A. Myers, T. Lloyd, and L. M. Demers. Determination of peak trabecular bone density: interplay of dietary fibre, carbohydrate, andand rogens. Am. J. Clin. Nutr. 50: 955-961, 1989.
13. Luthy, I., S. Caron, A. Belanger, and F. Labrie. Effects of flutamide, a pure antiandrogen, on endocrine parameters, in the adult rat. Gynecol. Endocrinol. 1: 151-168, 1987.
14. Malluche, H. H., M.-C. Faugere, M. Rush, and R. M. Friedler. Osteoblastic insufficiency is responsible for maintenance of osteopenia after loss of ovarian function in experimental Beagle dogs. Endocrinology 119: 2649-2654, 1986.
15. Moguilewsky, M., J. Fiet, C. Tournemine, and J.-P. Raynaud. Pharmacology of an antiandrogen, anandron, used as an adjuvant therapy in the treatment of prostate cancer. J. Steroid Biochem. 24: 139-146, 1986.
16. Mooradian, A. D., J. E. Morley, and S. G. Korenman. Biological actions of androgens. Endocr. Rev. 8: 1-28, 1987.
17. Neri, R. Pharmacology and pharmacokinetics of flutamide. Urology 34, Suppl. 4: 19-21, 1989.
18. Orwoll, E. S., L. Stribrska, E. E. Ramsey, and E. J. Keenan. Androgen receptors in osteoblast-like cell lines. Calcif. Tiss. Int. 49: 183-187, 1991.
19. Oursler, M. J., B. L. Riggs, and T. C. Speisberg. Androgen action on avian osteoclasts and human giant cell tumours of the bone (Abstract). J. Bone Miner. Res. 8, Suppl. 1: S387, 1993.
20. Parfitt, A. M. The coupling of bone formation to bone resorption. A critical analysis of the concept and of its relevance to the pathogenesis of osteoporosis. Metab. Bone Dis. Relat. Res. 4: 1-8, 1982.
21. Parfitt, A. M. The physiological and clinical significance of bone histomorphometric data. In: Bone Histomorphometry. Techniques and Interpretation, edited by R. R. Recker. Boca Raton, FL: CRC, 1983, p. 143-223.
22. Parfitt, A. M., C. L. E. Matthews, A. R. Villaneuva, M. Kleerkoper, B. Frame, and D. S. Rao. Relationships between surface, volume and thickness of iliac trabecular bone in aging and in osteoporosis. J. Clin. Invest. 72: 1396-1409, 1983.
23. Simmons, D. J. Collagen formation and endochondral ossification in estrogen-treated mice. Proc Soc. Exp Biol. Med. 121: 1165-1168, 1966.
24. Stepan, J. J., J. Presl, P. Broulik, and V. Pacovsky. Serum osteocalcin levels and bone alkaline phosphatase isoenzyme after oophorectomy and primary hyperparathyroidism. J. Clin. Endocrinol. Metab. 64: 1079-1084, 1987.
25. Takano-Yamamoto, T., and G. A. Rodan. Direct effects of 17β-estradiol on trabecular bone in ovariectomised rats. Proc. Natl. Acad. Sci. USA 87: 2172-2176, 1990.
26. Tobias, J. H., A. Gallagher, and T. J. Chambers. 5α-Dihydrotestosterone partially restores cancellous bone volume in osteopenic ovariectomised rats. Am. J. Physiol. 267 (Endocrinol. Metab. 30): E853-E859, 1994.
27. Vanderschueren, D., E. Van Herck, A. M. H. Suiker, W. J. Visser, L. P. C. Scot, and R. Bouillon. Bone and mineral metabolism in aged male rats: short and longterm effects of androgen deficiency. Endocrinology 130: 2906-2916, 1992.
28. Wakley, G. K., J. Schutte, H. D., K. S. Hannon, and R. T. Turner. Androgen treatment prevents loss of cancellous bone in the orchidectomised rat. J. Bone Miner. Res. 6: 325-330, 1991.
29. Westerlind, K. C., G. K. Wakley, G. L. Evans, and R. T. Turner. Estrogen doses not increase bone formation in growing rats. Endocrinology 133: 2924-2934, 1994.
30. Wronski, T. J., M. Cintron, A. L. Doherty, and L. M. Dann. Estrogen treatment prevents osteopenia and depresses bone turnover in ovariectomized rats. Endocrinology 123: 681-686, 1988.
31. Wronski, T. J., L. M. Dann, K. S. Scott, and L. R. Crooke. Endocrine and pharmacological suppressors of bone turnover protect against osteopenia in ovariectomised rats. Endocrinology 125: 810-816, 1989.